Results 81 to 90 of about 8,347 (150)

HLA-DR3 ~ DQ2 associates with sensory neuropathy in paraneoplastic neurological syndromes with Hu antibodies. [PDF]

open access: yesJ Neurol
Muñiz-Castrillo S   +8 more
europepmc   +1 more source

Paraneoplastic Neurological Syndromes as Initial Presentation of Tumors: An Eight-Year Single-Center Experience. [PDF]

open access: yesJ Clin Med
Melanis K   +14 more
europepmc   +1 more source

Significant improvement in paraneoplastic neurological syndromes without identifiable anti-neural antibodies in patients with breast cancer after breast surgery. [PDF]

open access: yesInt Cancer Conf J
Oshino T   +9 more
europepmc   +1 more source

Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes. [PDF]

open access: yesAnn Clin Transl Neurol, 2017
van Coevorden-Hameete MH   +12 more
europepmc   +1 more source

Lung Cancer Wherein Durvalumab Induced Both Anti-CRMP-5 Antibody-related Paraneoplastic Neurological Syndromes and Neurological Adverse Events. [PDF]

open access: yesIntern Med
Seki T   +10 more
europepmc   +1 more source

Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies. [PDF]

open access: yesJ Neurol Neurosurg Psychiatry, 2018
Berzero G   +14 more
europepmc   +1 more source

Paraneoplastic Syndromes in Neurology

open access: yes
Paraneoplastic neurological syndromes (PNS) are a broad group of disorders affecting central and peripheral nervous system which result from an unregulated immune response to the nervous system mediated by different types of neoplasms. The clinical features of PNS frequently appear prior a diagnosis of a neoplasm, therefore recognition of these ...
openaire   +1 more source

Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies. [PDF]

open access: yesJAMA Neurol, 2015
Ariño H   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy